Literature DB >> 2439402

Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.

G B Willars, N A Calcutt, D R Tomlinson.   

Abstract

This study examined anterograde and retrograde accumulation of axonally transported 6-phosphofructokinase activity, proximal and distal to sciatic nerve constrictions, in rats with streptozotocin-induced diabetes of 4 weeks' duration. There were deficits in accumulation on both sides of the constriction in untreated diabetic rats (proximal accumulation 66% of controls, p less than 0.05; distal accumulation 32% of controls, p less than 0.01). There was also a reduction in the phosphofructokinase activity per unit length unconstricted sciatic nerve in the untreated diabetic rats (87% of controls, p less than 0.05). Treatment of an age-matched group of diabetic rats with twice-daily insulin prevented all the above changes. There were significant increases, over untreated diabetic rats, in phosphofructokinase activity accumulated at constrictions (p less than 0.01 for both proximal and distal) and in unconstricted nerve (p less than 0.05). Indeed the activities measured in insulin-treated diabetic rats were virtually identical to those of controls. Treatment of a third group of diabetic rats with the aldose reductase inhibitor 'Statil' prevented or attenuated accumulations of polyol pathway metabolites and prevented depletion of myo-inositol in the sciatic nerve. In spite of these indications of effective aldose reductase inhibition, the drug was without effect on the deficits in accumulation of activity at ligatures or unconstricted nerve levels of phosphofructokinase activity. We conclude that short-term experimental diabetes in rats induced defects in both anterograde and retrograde axonal transport of 6-phosphofructokinase activity. These defects were prevented by intensive insulin treatment but were resistant to an effective aldose reductase inhibitor, indicating a lack of involvement of polyol pathway flux in their pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439402     DOI: 10.1007/bf00270422

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  24 in total

1.  Diabetic neuropathy. Vibration sense and abnormal tendon reflexes in diabetics.

Authors:  I STEINESS
Journal:  Acta Med Scand Suppl       Date:  1963

2.  The experimental neuropathy in rats caused by p-bromophenylacetylurea.

Authors:  J B Cavanagh; F C Chen; M H Kyu; A Ridley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-10       Impact factor: 10.154

3.  Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients.

Authors:  G Gregersen
Journal:  Diabetologia       Date:  1968-11       Impact factor: 10.122

Review 4.  Defects of axonal transport in diabetes mellitus--a possible contribution to the aetiology of diabetic neuropathy.

Authors:  D R Tomlinson; J H Mayer
Journal:  J Auton Pharmacol       Date:  1984-03

5.  Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.

Authors:  J H Mayer; D R Tomlinson
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

6.  Axonal transport of cholinergic transmitter enzymes in vagus and sciatic nerves of rats with acute experimental diabetes mellitus; correlation with motor nerve conduction velocity and effects of insulin.

Authors:  J H Mayer; D R Tomlinson
Journal:  Neuroscience       Date:  1983-08       Impact factor: 3.590

7.  Reversibility and preventability of the decrease in slow axonal transport velocity in experimental diabetes.

Authors:  P Sidenius; J Jakobsen
Journal:  Diabetes       Date:  1982-08       Impact factor: 9.461

8.  Sodium-potassium-ATPase activity in the dorsal root ganglia of rats with streptozotocin-induced diabetes.

Authors:  R J Green; R H King; P K Thomas; D N Baron
Journal:  Diabetologia       Date:  1985-02       Impact factor: 10.122

9.  Ischemic conduction failure and energy metabolism in experimental diabetic neuropathy.

Authors:  P A Low; K Ward; J D Schmelzer; S Brimijoin
Journal:  Am J Physiol       Date:  1985-04

10.  Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.

Authors:  D R Tomlinson; R J Moriarty; J H Mayer
Journal:  Diabetes       Date:  1984-05       Impact factor: 9.461

View more
  7 in total

1.  Delayed recovery of nerve conduction and vibratory sensibility after ischaemic block in patients with diabetes mellitus.

Authors:  P Lindström; U Lindblom; T Brismar
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

Review 2.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

3.  Essential fatty acid treatment--effects on nerve conduction, polyol pathway and axonal transport in streptozotocin diabetic rats.

Authors:  D R Tomlinson; J P Robinson; A M Compton; P Keen
Journal:  Diabetologia       Date:  1989-09       Impact factor: 10.122

4.  Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.

Authors:  C Pekiner; W G McLean
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

5.  Vasoreactivity and prostacyclin release in streptozotocin-diabetic rats: effects of insulin or aldose reductase inhibition.

Authors:  E J Stevens; G B Willars; P Lidbury; F House; D R Tomlinson
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 6.  Impairment of Axonal Transport in Diabetes: Focus on the Putative Mechanisms Underlying Peripheral and Central Neuropathies.

Authors:  Filipa I Baptista; Helena Pinheiro; Catarina A Gomes; António F Ambrósio
Journal:  Mol Neurobiol       Date:  2018-07-12       Impact factor: 5.590

7.  Adenosine triphosphatase in nerves and ganglia of rats with streptozotocin-induced diabetes or galactosaemia; effects of aldose reductase inhibition.

Authors:  J E Lambourne; A M Brown; N Calcutt; D R Tomlinson; G B Willars
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.